Plethico Pharmaceuticals: Updates

Plethico Pharmaceuticals Ltd has informed BSE that:

'With a view to address the delay in repayment of principal and interest on fixed deposits, service banking facilities, pay statutory dues and sustain its business operations, the Company has opted to adopt contract manufacturing model for its operation. Further, with a view to maintain existing market share in various geographies, the Company is tying up with prominent distributors present in those geographies and entering binding agreements with them on exclusive and non-exclusive basis, for distribution of the products manufactured by the Company with conducive terms in payment and credit period.'